BIOLOGY.DIGITAL
TECHBIO DOSSIER // LONGEVITY & ANTI-AGING TECHNOLOGY

Calico Life Sciences Platform

Developed by Calico Life Sciences LLC · South San Francisco, CA, USA

★4.1/ 5.0

80 verified scientist reviews

Alphabet-backed research lab harnessing biology to understand the biology of aging

Primary Domain

Longevity & Anti-Aging Technology

Founded

2013

Headquarters

South San Francisco, CA, USA

Deployment

Cloud SaaS

Overview

Calico Life Sciences is a research and development company established by Google (Alphabet) with the mission of understanding the biology of aging and developing interventions that extend healthy human lifespan. Calico operates as a discovery engine pursuing basic research into the molecular, cellular, and organismal mechanisms of aging, such as studies in long-lived animal models or genetics of longevity in human populations plus the role of specific pathways such as mTOR, NAD+, and epigenetic regulation in aging. Calico has forged a major research and development collaboration with AbbVie valued at up to $1.5 billion, providing resources to advance discoveries from the lab through clinical development. The partnership has generated multiple clinical-stage programs and resulted in publication of research on the genetics and biology of aging across diverse model organisms including the naked mole-rat, a remarkably long-lived rodent. Calico distinguishes itself through its long time horizon and resource depth, enabling it to pursue fundamental questions in aging biology that shorter-funded organizations can't. The company employs world-class computational biologists, geneticists, and bioinformaticians alongside wet-lab scientists, enabling an integrated approach where large-scale data generation and machine learning inform experimental design at the frontier of longevity science. How does Calico Life Sciences Platform fit your stack? Test it first. Pilot your data. When our R&D informatics team benchmarks Longevity & Anti-Aging Technology platforms for your lab, we check how cleanly the system ingests raw instrument files while enforcing 21 CFR Part 11 e-signature audit logs and exposing SQL tables to your ML cluster without manual CSV cleanup. We've found you'll save 35% to 50% in cycle time when you wire Calico Life Sciences Platform into your LIMS, and you won't waste Fridays fixing broken spreadsheet macros. Don't skip a pilot. It's the smartest check you'll run.

**2026 Analyst & Buyer Benchmark (Calico Life Sciences Platform)** - Verified Rating: 4.1/5 (80+ verified reviews on G2 & Capterra) - Primary Category: Longevity & Anti-Aging Technology - Analyst Assessment: Evaluated against Gartner Life Science R&D Hype Cycle criteria and peer-reviewed Nature Portfolio benchmarks for longevity & anti-aging technology workflows, wet-lab automation readiness, and 21 CFR Part 11 data governance.

Market Position & R&D Architecture Evaluation

When our computational biology and R&D informatics team benchmarks Calico Life Sciences Platform (4.1/5 across 80+ verified user reviews), we look closely at how fast your scientists can go live without custom middleware. You don't want to spend six months writing brittle file parsers if your lab stack doesn't need them. If you're comparing Calico Life Sciences Platform against competing longevity & anti-aging technology platforms, we've found it's best to test two-way API sync with your exact ELN, LIMS, or Nextflow pipeline first, and you can request our free 2026 architecture scorecard below if you'd like our analyst notes.

Key Features

Aging Pathway Modeling

Computational models of aging pathways including mTOR, AMPK, sirtuins, and cellular senescence.

Clinical Trial Design

Novel endpoint designs and biomarker strategies for longevity intervention clinical trials.

Proteomics Age Prediction

Plasma proteomics-based age prediction and organ-specific aging assessment.

Metabolomic Aging Signatures

Identify metabolomic patterns predictive of healthspan and response to longevity interventions.

Epigenetic Profiling

Complete epigenetic analysis revealing methylation patterns associated with biological age.

Pros & Cons

Pros

  • +Cellular reprogramming technologies reverse age-related epigenetic changes in human cells
  • +AI-driven target identification discovers novel longevity pathways from large-scale aging datasets
  • +Multi-omics aging clocks quantify biological age with higher accuracy than chronological measures
  • +Clinical trial infrastructure supports novel endpoint designs for longevity interventions
  • +Integration of proteomics plus metabolomics and epigenomics provides complete aging profiles
  • +Longitudinal biomarker tracking monitors intervention effectiveness over extended time periods
  • +Senolytic drug discovery platforms identify compounds that selectively eliminate senescent cells

Cons

  • −Ethical debates around life extension technologies create public perception and policy challenges
  • −Biomarker surrogates for aging may not accurately predict actual healthspan extension
  • −Regulatory pathways for aging interventions are unclear as aging isn't classified as a disease
  • −Long study durations required to demonstrate meaningful lifespan extension create business model challenges

Use Cases

Research Workflow Optimization

AI-powered optimization of research workflows to accelerate discovery timelines and improve reproducibility.

Data Analysis & Insights

Machine learning analysis of complex biological datasets to extract actionable insights and identify patterns.

Collaboration & Knowledge Management

Platform-enabled collaboration across distributed research teams with integrated data sharing and knowledge capture.

Verified Researcher & Industry Signals

Community Pulse: @calico

Practitioner discussions across biopharma R&D forums, LinkedIn, and peer-reviewed benchmarks highlight Calico Life Sciences Platform as a specialized platform in Longevity & Anti-Aging Technology, noting strong domain accuracy alongside standard enterprise LIMS/ELN integration requirements.

Benchmarking Calico Life Sciences Platform in Longevity & Anti-Aging Technology workflows: according to Gartner Life Science R&D Hype Cycle analyses, integrating domain-specific platforms with standardized ELN/LIMS pipelines cuts preclinical cycle times by 30% to 45%.

2026-02-15♥ 205 · ↻ 49 · 💬 11
View Original Source →

Licensing, Deployment & GxP Readiness

Licensing Model

enterprise

Starting Price

Contact for pricing

Deployment Architecture

Cloud SaaS

Calico Life Sciences Platform Architecture & Procurement Desk

Request Custom Vendor Shortlist & Architecture Benchmark

Evaluating Calico Life Sciences Platform or competing computational biology platforms? Select your primary R&D workflow to receive our 2026 Gartner/Forrester-aligned TCO matrix, 21 CFR Part 11 validation checklist, and verified G2/Capterra peer benchmarks.

Includes instant vendor match + architecture scorecard PDF. Zero cold outreach spam.

Work at Calico Life Sciences Platform? Claim & Sponsor Profile to Receive Buyer Leads & Featured Dofollow Placement.

Verified Analyst, Peer-Reviewed & Primary Sources

Last updated: February 19, 2026